191 related articles for article (PubMed ID: 33576839)
21. A patient with extensive cerebral calcification due to pseudohypoparathyroidism: a case report.
De Silva SW; De Silva SDN; De Silva CE
BMC Endocr Disord; 2019 Dec; 19(1):142. PubMed ID: 31856822
[TBL] [Abstract][Full Text] [Related]
22. Dental Findings in Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism: A Systematic Review.
Hejlesen J; Underbjerg L; Gjørup H; Bloch-Zupan A; Sikjaer T; Rejnmark L; Haubek D
Front Physiol; 2018; 9():701. PubMed ID: 29971010
[No Abstract] [Full Text] [Related]
23. Skeletal responsiveness to parathyroid hormone in pseudohypoparathyroidism.
Kanatani M; Sugimoto T; Kaji H; Ikeda K; Chihara K
Eur J Endocrinol; 2001 Mar; 144(3):263-9. PubMed ID: 11248746
[TBL] [Abstract][Full Text] [Related]
24. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism.
Breslau NA; Moses AM; Pak CY
J Clin Endocrinol Metab; 1983 Sep; 57(3):638-44. PubMed ID: 6688258
[TBL] [Abstract][Full Text] [Related]
25. Effect of calcium administration on renal responsiveness to parathyroid hormone in pseudohypoparathyroidism type I and II -- in comparison with normals, idiopathic and surgical hypoparathyroidism.
Yamada K; Tamura Y; Yamamoto M; Kumagai A
Endocrinol Jpn; 1979 Apr; 26(2):147-57. PubMed ID: 225161
[TBL] [Abstract][Full Text] [Related]
26. PTH and bone material strength in hypoparathyroidism as measured by impact microindentation.
Starr JR; Tabacco G; Majeed R; Omeragic B; Bandeira L; Rubin MR
Osteoporos Int; 2020 Feb; 31(2):327-333. PubMed ID: 31720712
[TBL] [Abstract][Full Text] [Related]
27. Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Mizunashi K; Furukawa Y; Goto MM; Abe K
Calcif Tissue Int; 1998 Apr; 62(4):290-4. PubMed ID: 9504951
[TBL] [Abstract][Full Text] [Related]
28. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
Stögmann W
Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
[TBL] [Abstract][Full Text] [Related]
29. A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects.
McElduff A; Lissner D; Wilkinson M; Cornish C; Posen S
Calcif Tissue Int; 1987 Nov; 41(5):267-73. PubMed ID: 2825934
[TBL] [Abstract][Full Text] [Related]
30. Renal complications in chronic hypoparathyroidism - a systematic cross-sectional assessment.
Gronemeyer K; Fuss CT; Hermes F; Plass A; Koschker AC; Hannemann A; Völzke H; Hahner S
Front Endocrinol (Lausanne); 2023; 14():1244647. PubMed ID: 38027217
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of pseudohypoparathyroidism type I from the aspect of urinary excretion of calcium and serum levels of parathyroid hormone.
Mizunashi K; Furukawa Y; Sohn HE; Miura R; Yumita S; Yoshinaga K
Calcif Tissue Int; 1990 Apr; 46(4):227-32. PubMed ID: 2108792
[TBL] [Abstract][Full Text] [Related]
32. Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Miura R; Yumita S; Yoshinaga K; Furukawa Y
Calcif Tissue Int; 1990 May; 46(5):309-13. PubMed ID: 2159833
[TBL] [Abstract][Full Text] [Related]
33. Pseudohypoparathyroidism type 1B - a rare cause of tetany: case report.
Garcia C; Correia CR; Lopes L
Paediatr Int Child Health; 2018 Nov; 38(4):281-284. PubMed ID: 28648114
[TBL] [Abstract][Full Text] [Related]
34. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
35. A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.
Kruse K; Kracht U
Eur J Pediatr; 1987 Jul; 146(4):373-7. PubMed ID: 2820733
[TBL] [Abstract][Full Text] [Related]
36. [Urinary phosphate and cyclic adenosine monophosphate response to intravenous administration of synthetic human parathyroid hormone-(1-34) in idiopathic hypoparathyroidism, pseudohypoparathyroidism, pseudopseudohypoparathyroidism and normal subjects].
Fukami T; Fujita T; Yoshimoto Y; Fukase M; Imai Y; Sakaguchi K; Ogata E; Furukawa Y; Suzuki H; Takebe K
Nihon Naibunpi Gakkai Zasshi; 1984 Mar; 60(3):159-70. PubMed ID: 6090236
[TBL] [Abstract][Full Text] [Related]
37. Prevalences of CT-detected calcification in the basal ganglia in idiopathic hypoparathyroidism and pseudohypoparathyroidism.
Illum F; Dupont E
Neuroradiology; 1985; 27(1):32-7. PubMed ID: 3974864
[TBL] [Abstract][Full Text] [Related]
38. The Management of Permanent Primary Hypoparathyroidism in Children and Adolescents: A Complex Task.
De Sanctis V; Soliman AT; Di Maio S; Kattamis C
Pediatr Endocrinol Rev; 2018 Sep; 16(1):194-202. PubMed ID: 30371038
[TBL] [Abstract][Full Text] [Related]
39. The modulatory effect of endogenous parathyroid hormone on the action of hydrochlorothiazide in pseudohypoparathyroidism type I.
Mizunashi K; Furukawa Y; Abe K; Yoshinaga K
Calcif Tissue Int; 1994 Jun; 54(6):473-6. PubMed ID: 8082049
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of 1,25-dihydroxyvitamin D production by parathyroid hormone and dibutyryl 3',5'-cyclic AMP in normal subjects, hypoparathyroidism and pseudohypoparathyroidism.
Unakami H; Furukawa Y; Sohn HE; Yumita S; Miura R; Hanew K; Yoshinaga K
Tohoku J Exp Med; 1982 Oct; 138(2):167-75. PubMed ID: 6294914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
